{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=All-cause+Mortality&page=2", "query": { "condition": "All-cause Mortality", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=All-cause+Mortality&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-06-26T04:36:24.869Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02933034", "title": "Clinical Trial of Manganese-Enhanced MRI (MEMRI) to Assess Peri-Infarct Injury", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "ISCHEMIC CARDIOMYOPATHY" ], "interventions": [ { "name": "Manganese-enhanced MRI contrast reagent", "type": "DRUG" }, { "name": "Gadolinium-enhanced MRI contrast reagent", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Stanford University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 33, "start_date": "2015-04", "completion_date": "2019-02-03", "has_results": true, "last_update_posted_date": "2020-02-17", "last_synced_at": "2026-06-26T04:36:24.869Z", "location_count": 1, "location_summary": "Stanford, California", "locations": [ { "city": "Stanford", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02933034" }, { "nct_id": "NCT02047981", "title": "Mortality Reduction After Oral Azithromycin: Mortality Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Childhood Mortality" ], "interventions": [ { "name": "Azithromycin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of California, San Francisco", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "1 Month", "maximum_age": "60 Months", "sex": "ALL", "summary": "1 Month to 60 Months" }, "enrollment_count": 190238, "start_date": "2014-12", "completion_date": "2018-09", "has_results": true, "last_update_posted_date": "2022-11-08", "last_synced_at": "2026-06-26T04:36:24.869Z", "location_count": 2, "location_summary": "San Francisco, California • Baltimore, Maryland", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT02047981" }, { "nct_id": "NCT00940095", "title": "Clazosentan in Aneurysmal Subarachnoid Hemorrhage", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Aneurysmal Subarachnoid Hemorrhage" ], "interventions": [ { "name": "Clazosentan 5 m/h", "type": "DRUG" }, { "name": "Clazosentan 15 mg/h", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Idorsia Pharmaceuticals Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 577, "start_date": "2009-07-01", "completion_date": "2011-01-01", "has_results": false, "last_update_posted_date": "2018-07-09", "last_synced_at": "2026-06-26T04:36:24.869Z", "location_count": 29, "location_summary": "Glendale, California • San Francisco, California • Stanford, California + 21 more", "locations": [ { "city": "Glendale", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Stanford", "state": "California" }, { "city": "Englewood", "state": "Colorado" }, { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT00940095" }, { "nct_id": "NCT07224659", "title": "Exercise and Mortality in Middle-Aged and Older Adults", "overall_status": "NOT_YET_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Overall Survival (All-cause Mortality)" ], "interventions": [ { "name": "Control", "type": "BEHAVIORAL" }, { "name": "Exercise", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "City of Hope Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "55 Years", "maximum_age": "74 Years", "sex": "ALL", "summary": "55 Years to 74 Years" }, "enrollment_count": 19000, "start_date": "2026-04-01", "completion_date": "2026-08-06", "has_results": false, "last_update_posted_date": "2026-02-04", "last_synced_at": "2026-06-26T04:36:24.869Z", "location_count": 1, "location_summary": "Duarte, California", "locations": [ { "city": "Duarte", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07224659" }, { "nct_id": "NCT07209098", "title": "Propensity-Matched Study of Cardiac Contractility Modulation Therapy in Heart Failure", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Heart Failure and Reduced Ejection Fraction", "NYHA Class III Heart Failure" ], "interventions": [ { "name": "Cardiac Contractility Modulation (CCM)", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Impulse Dynamics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 4200, "start_date": "2025-11-18", "completion_date": "2031-04", "has_results": false, "last_update_posted_date": "2026-03-24", "last_synced_at": "2026-06-26T04:36:24.869Z", "location_count": 1, "location_summary": "Marlton, New Jersey", "locations": [ { "city": "Marlton", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT07209098" }, { "nct_id": "NCT07563777", "title": "100-Year Human Aging Study", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Aging", "Aging Well", "All-Cause Mortality", "Mortality", "Metabolic Syndrome", "Cardiovascular Diseases", "Cognitive Dysfunction", "Musculoskeletal Diseases", "Neoplasms", "Frailty", "Activities of Daily Living", "Health-Related Quality of Life", "Disability Physical", "Neuro-Degenerative Disease", "Dementia" ], "interventions": [ { "name": "Comprehensive Multi-System Clinical Screening", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Longevity Metrics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1000000, "start_date": "2025-02-09", "completion_date": "2099-12-31", "has_results": false, "last_update_posted_date": "2026-06-11", "last_synced_at": "2026-06-26T04:36:24.869Z", "location_count": 1, "location_summary": "Boulder, Colorado", "locations": [ { "city": "Boulder", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT07563777" }, { "nct_id": "NCT05085275", "title": "Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Anemia, Iron Deficiency", "Hyperphosphatemia", "Renal Insufficiency, Chronic", "Renal Anemia", "Disease Progression", "Cardiovascular", "Iron" ], "interventions": [ { "name": "Ferric Citrate 1 GM Oral Tablet [AURYXIA]", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "USRC Kidney Research", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 289, "start_date": "2022-03-30", "completion_date": "2024-01-24", "has_results": true, "last_update_posted_date": "2025-08-29", "last_synced_at": "2026-06-26T04:36:24.869Z", "location_count": 23, "location_summary": "Pine Bluff, Arkansas • Chula Vista, California • El Centro, California + 16 more", "locations": [ { "city": "Pine Bluff", "state": "Arkansas" }, { "city": "Chula Vista", "state": "California" }, { "city": "El Centro", "state": "California" }, { "city": "Escondido", "state": "California" }, { "city": "La Mesa", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05085275" }, { "nct_id": "NCT00793013", "title": "Airway Pressure Release Ventilation (APRV) Compared to ARDSnet Ventilation", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acute Lung Injury", "Adult Respiratory Distress Syndrome", "Kidney Injury" ], "interventions": [ { "name": "Volume-Cycled Assist-Control (AC) mode", "type": "DEVICE" }, { "name": "Airway Pressure Release Ventilation (APRV) mode", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "University of Tennessee, Chattanooga", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 0, "start_date": "2020-11-02", "completion_date": "2020-11-02", "has_results": false, "last_update_posted_date": "2020-11-04", "last_synced_at": "2026-06-26T04:36:24.869Z", "location_count": 1, "location_summary": "Chattanooga, Tennessee", "locations": [ { "city": "Chattanooga", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT00793013" }, { "nct_id": "NCT00358215", "title": "RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Heart Failure", "Anemia", "Cardiovascular Disease", "Ventricular Dysfunction", "Congestive Heart Failure" ], "interventions": [ { "name": "Darbepoetin alfa", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Amgen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2278, "start_date": "2006-06-01", "completion_date": "2012-10-11", "has_results": true, "last_update_posted_date": "2022-11-08", "last_synced_at": "2026-06-26T04:36:24.869Z", "location_count": 254, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Mobile, Alabama + 195 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Gilbert", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00358215" }, { "nct_id": "NCT02656329", "title": "International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Heart Failure" ], "interventions": [ { "name": "Iobenguane I -123 Injection", "type": "DRUG" }, { "name": "Implantable Cardioverter Defibrillator", "type": "DEVICE" }, { "name": "Thyroid blocking", "type": "DRUG" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "GE Healthcare", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 395, "start_date": "2015-12-30", "completion_date": "2018-05-04", "has_results": true, "last_update_posted_date": "2019-05-22", "last_synced_at": "2026-06-26T04:36:24.869Z", "location_count": 29, "location_summary": "Birmingham, Alabama • Bakersfield, California • La Mesa, California + 24 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Bakersfield", "state": "California" }, { "city": "La Mesa", "state": "California" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "West Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT02656329" } ] }